SciELO - Scientific Electronic Library Online

 
vol.14 número1Review of the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) version 2:2015Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

    Links relacionados

    • En proceso de indezaciónCitado por Google
    • En proceso de indezaciónSimilares en Google

    Compartir


    African Journal of Laboratory Medicine

    versión On-line ISSN 2225-2010versión impresa ISSN 2225-2002

    Resumen

    NHLAPO, Nokuthula; JACOB, Doreen; KHOZA, Siyabonga  y  MAPHAYI, Mpho R.. Comparison of second and third-generation parathyroid hormone assays at a tertiary hospital in South Africa. Afr. J. Lab. Med. [online]. 2025, vol.14, n.1, pp.1-8. ISSN 2225-2010.  https://doi.org/10.4102/ajlm.v14i1.2700.

    BACKGROUND: Parathyroid hormone (PTH) measurement is key for diagnosing parathyroid disorders, and for management of chronic kidney disease. Available PTH assays include second (intact PTH) and third (PTH 1-84) generations. Data comparing interchangeable use are insufficient OBJECTIVE: The objective of this study was to compare intact and 1-84 PTH assays to determine the difference in analytical performance and impact on clinical interpretation METHODS: A method comparison was done on residual samples with PTH requests (06 April 2022 - 21 September 2022) from a tertiary hospital in South Africa. Parathyroid hormone was measured using both intact PTH and 1-84 PTH assays. Clinical performance was compared in the diagnosis of hypo- and hyperparathyroidism, and in pre-dialysis and dialysis chronic kidney disease patients RESULTS: Among 481 samples, intact PTH had a higher median concentration than PTH 1-84 (9.85 pmol/L vs. 8.51 pmol/L, p < 0.0001), but the two showed good correlation (r = 0.994, p < 0.0001). Regression analysis revealed systematic (intercept = 0.887 pmol/L [95% confidence interval: 0.788 - 1.005]) and proportional differences (slope = 0.713 pmol/L, [95% confidence interval: 0.703 - 0.723]), with increased deviations at higher concentrations. The average bias was 18.5%, exceeding allowable limits. Among the 276 patients (170 women, 106 men, age range: 18-89 years) included in the clinical study, interpretation was unchanged CONCLUSION: A bias was observed between the PTH assays, indicating that they should not be used interchangeably. However, no changes in clinical interpretation were observed when one assay was used over the other WHAT THIS STUDY ADDS: The study confirms the recommendation by Kidney Disease: Improving Global Outcomes for the use of assay-specific upper limit of normal instead of generic cut-off in dialysis patients. This study further highlights the need for standardisation of PTH assays

    Palabras clave : parathyroid hormone; second-generation PTH assays (intact PTH); third-generation PTH assays (PTH 1-84); chronic kidney disease; dialysis; method comparison; bias, estimated glomerular filtration rate; hyperparathyroidism.

            · texto en Inglés     · Inglés ( pdf )